Crossmark

Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson’s disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy

Crossref DOI link: https://doi.org/10.1186/s13041-023-00996-1

Published Online: 2023-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Jieun

Han, Jung-Youn

Lee, Yujeong

Kim, Kipom

Choi, Young Pyo

Chae, Sehyun

Hoe, Hyang-Sook https://orcid.org/0000-0001-8877-8594
Funding

Funding for this research was provided by:

KBRI (22-BR-02-12, 22-BR-02-03, 19-BR-03-03, 22-BR-01-02, 22-BR-05-02)
License Information

Text and Data Mining valid from 2023-01-16

Version of Record valid from 2023-01-16
More Information

Article History

Received: 11 November 2022

Accepted: 2 January 2023

First Online: 16 January 2023

Declarations

:

: All animal experiments were approved by the Institutional Animal Care and Use Committee of the Korea Brain Research Institute (KBRI) (Approval Nos. IACUC-18-0007 and IACUC-19-0010).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below